BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

405 related articles for article (PubMed ID: 31603063)

  • 1. Overview of the role of kinetoplastid surface carbohydrates in infection and host cell invasion: prospects for therapeutic intervention.
    Valente M; Castillo-Acosta VM; Vidal AE; González-Pacanowska D
    Parasitology; 2019 Dec; 146(14):1743-1754. PubMed ID: 31603063
    [TBL] [Abstract][Full Text] [Related]  

  • 2. The kinetoplastid chemotherapy revisited: current drugs, recent advances and future perspectives.
    Castillo E; Dea-Ayuela MA; Bolás-Fernández F; Rangel M; González-Rosende ME
    Curr Med Chem; 2010; 17(33):4027-51. PubMed ID: 20939823
    [TBL] [Abstract][Full Text] [Related]  

  • 3. In vitro evaluation of arylsubstituted imidazoles derivatives as antiprotozoal agents and docking studies on sterol 14α-demethylase (CYP51) from Trypanosoma cruzi, Leishmania infantum, and Trypanosoma brucei.
    Rojas Vargas JA; López AG; Pérez Y; Cos P; Froeyen M
    Parasitol Res; 2019 May; 118(5):1533-1548. PubMed ID: 30903349
    [TBL] [Abstract][Full Text] [Related]  

  • 4. An Overview on Target-Based Drug Design against Kinetoplastid Protozoan Infections: Human African Trypanosomiasis, Chagas Disease and Leishmaniases.
    Kourbeli V; Chontzopoulou E; Moschovou K; Pavlos D; Mavromoustakos T; Papanastasiou IP
    Molecules; 2021 Jul; 26(15):. PubMed ID: 34361781
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Systematic study of 1,2,3-triazolyl sterols for the development of new drugs against parasitic Neglected Tropical Diseases.
    Porta EOJ; Ballari MS; Carlucci R; Wilkinson S; Ma G; Tekwani BL; Labadie GR
    Eur J Med Chem; 2023 Jun; 254():115378. PubMed ID: 37084599
    [TBL] [Abstract][Full Text] [Related]  

  • 6. The Dialogue of the Host-Parasite Relationship: Leishmania spp. and Trypanosoma cruzi Infection.
    de Morais CG; Castro Lima AK; Terra R; dos Santos RF; Da-Silva SA; Dutra PM
    Biomed Res Int; 2015; 2015():324915. PubMed ID: 26090399
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Novel compounds to combat trypanosomatid infections: a medicinal chemical perspective.
    González M; Cerecetto H
    Expert Opin Ther Pat; 2011 May; 21(5):699-715. PubMed ID: 21428846
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Screening a Natural Product-Based Library against Kinetoplastid Parasites.
    Zulfiqar B; Jones AJ; Sykes ML; Shelper TB; Davis RA; Avery VM
    Molecules; 2017 Oct; 22(10):. PubMed ID: 29023425
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Molecular basis of Trypanosoma cruzi and Leishmania interaction with their host(s): exploitation of immune and defense mechanisms by the parasite leading to persistence and chronicity, features reminiscent of immune system evasion strategies in cancer diseases.
    Ouaissi A; Ouaissi M
    Arch Immunol Ther Exp (Warsz); 2005; 53(2):102-14. PubMed ID: 15928579
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Targeting the polyamine biosynthetic enzymes: a promising approach to therapy of African sleeping sickness, Chagas' disease, and leishmaniasis.
    Heby O; Persson L; Rentala M
    Amino Acids; 2007 Aug; 33(2):359-66. PubMed ID: 17610127
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Macromolecular Targets of Antiparasitic Germacranolide Sesquiterpenoids: An
    Arnston PM; Setzer WN
    Comb Chem High Throughput Screen; 2020; 23(6):477-503. PubMed ID: 32067612
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Proteasome inhibition for treatment of leishmaniasis, Chagas disease and sleeping sickness.
    Khare S; Nagle AS; Biggart A; Lai YH; Liang F; Davis LC; Barnes SW; Mathison CJ; Myburgh E; Gao MY; Gillespie JR; Liu X; Tan JL; Stinson M; Rivera IC; Ballard J; Yeh V; Groessl T; Federe G; Koh HX; Venable JD; Bursulaya B; Shapiro M; Mishra PK; Spraggon G; Brock A; Mottram JC; Buckner FS; Rao SP; Wen BG; Walker JR; Tuntland T; Molteni V; Glynne RJ; Supek F
    Nature; 2016 Sep; 537(7619):229-233. PubMed ID: 27501246
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Targeting calcium homeostasis as the therapy of Chagas' disease and leishmaniasis - a review.
    Benaim B; Garcia CR
    Trop Biomed; 2011 Dec; 28(3):471-81. PubMed ID: 22433874
    [TBL] [Abstract][Full Text] [Related]  

  • 14. High-throughput screening platform for natural product-based drug discovery against 3 neglected tropical diseases: human African trypanosomiasis, leishmaniasis, and Chagas disease.
    Annang F; Pérez-Moreno G; García-Hernández R; Cordon-Obras C; Martín J; Tormo JR; Rodríguez L; de Pedro N; Gómez-Pérez V; Valente M; Reyes F; Genilloud O; Vicente F; Castanys S; Ruiz-Pérez LM; Navarro M; Gamarro F; González-Pacanowska D
    J Biomol Screen; 2015 Jan; 20(1):82-91. PubMed ID: 25332350
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Design, Synthesis and Antiparasitic Evaluation of Click Phospholipids.
    Magoulas GE; Afroudakis P; Georgikopoulou K; Roussaki M; Borsari C; Fotopoulou T; Santarem N; Barrias E; Tejera Nevado P; Hachenberg J; Bifeld E; Ellinger B; Kuzikov M; Fragiadaki I; Scoulica E; Clos J; Gul S; Costi MP; de Souza W; Prousis KC; Cordeiro da Silva A; Calogeropoulou T
    Molecules; 2021 Jul; 26(14):. PubMed ID: 34299479
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Rapid, Selection-Free, High-Efficiency Genome Editing in Protozoan Parasites Using CRISPR-Cas9 Ribonucleoproteins.
    Soares Medeiros LC; South L; Peng D; Bustamante JM; Wang W; Bunkofske M; Perumal N; Sanchez-Valdez F; Tarleton RL
    mBio; 2017 Nov; 8(6):. PubMed ID: 29114029
    [TBL] [Abstract][Full Text] [Related]  

  • 17. cAMP signalling in the kinetoplastid protozoa.
    Seebeck T; Schaub R; Johner A
    Curr Mol Med; 2004 Sep; 4(6):585-99. PubMed ID: 15357210
    [TBL] [Abstract][Full Text] [Related]  

  • 18. The Role of Flavanones as Scaffolds for the Development of New Treatments against Malaria and African and American Trypanosomiases.
    Boniface PK; Ferreira EI; Fabrice FB
    Mini Rev Med Chem; 2023; 23(14):1479-1498. PubMed ID: 36582061
    [TBL] [Abstract][Full Text] [Related]  

  • 19. The activities of four anticancer alkyllysophospholipids against Leishmania donovani, Trypanosoma cruzi and Trypanosoma brucei.
    Croft SL; Snowdon D; Yardley V
    J Antimicrob Chemother; 1996 Dec; 38(6):1041-7. PubMed ID: 9023651
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Design and preparation of sterol mimetics as potential antiparasitics.
    Gigante F; Kaiser M; Brun R; Gilbert IH
    Bioorg Med Chem; 2010 Oct; 18(20):7291-301. PubMed ID: 20846867
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 21.